Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Change in Accured Expenses: 2019-2024

Historic Change in Accured Expenses for Aveanna Healthcare Holdings (AVAH) over the last 5 years, with FY2024 value amounting to $20.5 million.

  • Aveanna Healthcare Holdings' Change in Accured Expenses fell 164.89% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year decrease of 6269.1%. This contributed to the annual value of $20.5 million for FY2024, which is 1205.63% down from last year.
  • Per Aveanna Healthcare Holdings' latest filing, its Change in Accured Expenses stood at $20.5 million for FY2024, which was down 1205.63% from $23.3 million recorded in FY2023.
  • Aveanna Healthcare Holdings' Change in Accured Expenses' 5-year high stood at $23.3 million during FY2023, with a 5-year trough of -$14.0 million in FY2022.
  • For the 4-year period, Aveanna Healthcare Holdings' Change in Accured Expenses averaged around $6.1 million, with its median value being $11.3 million (2021).
  • In the last 5 years, Aveanna Healthcare Holdings' Change in Accured Expenses plummeted by 22422.28% in 2022 and then skyrocketed by 31739.21% in 2023.
  • Over the past 4 years, Aveanna Healthcare Holdings' Change in Accured Expenses (Annual) stood at $11.3 million in 2021, then tumbled by 195.02% to -$10.7 million in 2022, then soared by 317.39% to $23.3 million in 2023, then dropped by 12.06% to $20.5 million in 2024.
  • Its last three reported values are $20.5 million in FY2024, $23.3 million for FY2023, and -$10.7 million during FY2022.